# Sana Biotechnology, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:efda9614-03aa-400b-958e-bfae693103b2 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/sana-biotechnology-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 27 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-19T14:44:08.722122+00:00 | | Last reviewed | 2026-10-19T14:44:08.722122+00:00 | ## Identity - Legal name: Sana Biotechnology, Inc. - Display name: Sana Biotechnology, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-19T14:44:08.722122+00:00 | | Completeness | 0.409 | | Record Quality | 0.828 | | Directors | 14 | | Committees | 4 | | Governance events | 7 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Alise S. Reicin: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. Committees: compensation and talent committee (member). claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:6 - Joshua H. Bilenker: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:8 - Mary Agnes Wilderotterº: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-24. Committees: audit committee (member); nominating and corporate governance committee (member). claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:10 - Patrick Y. Yang: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. Committees: nominating and corporate governance committee (member). claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:12 - Richard Mulligan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:14 - Robert Nelsen: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:17 - Alise S. Reicin, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:7 - Hans E. Bishop: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:5 - Joshua H. Bilenker, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:9 - Michelle Seitz, CFA: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:11 - Patrick Y. Yang, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:13 - Richard Mulligan, Ph.D.: Vice-Chairman of the Board. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:15 - Robert L. Rosiello: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:16 - Steven D. Harr, M.D.: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:18 ## Committees - audit committee (audit). Chair: NOT_PUBLISHED. Members: Mary Agnes Wilderotterº (member, current). committee_id=alpha:committee:sana-biotechnology-inc:audit-committee - Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: Steven D. Harr, M.D. (member, unknown). committee_id=alpha:committee:sana-biotechnology-inc:chief-executive-officer-and-director - compensation and talent committee (compensation). Chair: NOT_PUBLISHED. Members: Alise S. Reicin (member, current). committee_id=alpha:committee:sana-biotechnology-inc:compensation-and-talent-committee - nominating and corporate governance committee (nominating_governance). Chair: NOT_PUBLISHED. Members: Mary Agnes Wilderotterº (member, current); Patrick Y. Yang (member, current). committee_id=alpha:committee:sana-biotechnology-inc:nominating-and-corporate-governance-committee ## Executive leadership - Bernard J. Cassidy: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:19 - Steven D. Harr, M.D.: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:20 ## Governance events - DIRECTOR_APPOINTED: Mary Agnes Wilderotterº seat on Sana Biotechnology, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-19T14:44:08.722122+00:00. event_id=alpha:event:transition:fh1sisz96vlg - CFO_CHANGED: Bernard J. Cassidy executive of Sana Biotechnology, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-19T14:44:08.722122+00:00. event_id=alpha:event:transition:iyjljmw2m1w8 - DIRECTOR_APPOINTED: Alise S. Reicin seat on Sana Biotechnology, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-19T14:44:08.722122+00:00. event_id=alpha:event:transition:gj7spz1ukqdk7 - DIRECTOR_APPOINTED: Joshua H. Bilenker seat on Sana Biotechnology, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-19T14:44:08.722122+00:00. event_id=alpha:event:transition:17ivl2518uhnv5 - DIRECTOR_APPOINTED: Patrick Y. Yang seat on Sana Biotechnology, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:44:08.722122+00:00. event_id=alpha:event:transition:1avakkv19waif1 - DIRECTOR_APPOINTED: Richard Mulligan seat on Sana Biotechnology, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:44:08.722122+00:00. event_id=alpha:event:transition:1pe8ow71f6qkrr - DIRECTOR_APPOINTED: Robert Nelsen seat on Sana Biotechnology, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:44:08.722122+00:00. event_id=alpha:event:transition:nxjf3g1r4mtes ## Scoped resources - `alpha://company/sana-biotechnology-inc` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record - `alpha://company/sana-biotechnology-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=identity - `alpha://company/sana-biotechnology-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=corporate-structure - `alpha://company/sana-biotechnology-inc/board` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=board - `alpha://company/sana-biotechnology-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=committees - `alpha://company/sana-biotechnology-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=leadership - `alpha://company/sana-biotechnology-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=ownership - `alpha://company/sana-biotechnology-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=financials - `alpha://company/sana-biotechnology-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=capital-structure - `alpha://company/sana-biotechnology-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=compensation - `alpha://company/sana-biotechnology-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=governance - `alpha://company/sana-biotechnology-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=shareholder-governance - `alpha://company/sana-biotechnology-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=audit - `alpha://company/sana-biotechnology-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=legal - `alpha://company/sana-biotechnology-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=risk - `alpha://company/sana-biotechnology-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=cyber - `alpha://company/sana-biotechnology-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=ai-governance - `alpha://company/sana-biotechnology-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=agents - `alpha://company/sana-biotechnology-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=ecosystem - `alpha://company/sana-biotechnology-inc/events` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=events - `alpha://company/sana-biotechnology-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=relationships - `alpha://company/sana-biotechnology-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=assessments - `alpha://company/sana-biotechnology-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:committee_appointment:22: `{"kind":"committee_appointment","original_name":"audit committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:mary-agnes-wilderotter-sana","name":"Mary Agnes Wilderotterº"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:committee_appointment:24: `{"kind":"committee_appointment","original_name":"compensation and talent committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:alise-s-reicin-sana","name":"Alise S. Reicin"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:committee_appointment:26: `{"kind":"committee_appointment","original_name":"nominating and corporate governance committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:mary-agnes-wilderotter-sana","name":"Mary Agnes Wilderotterº"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:committee_appointment:27: `{"kind":"committee_appointment","original_name":"nominating and corporate governance committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:patrick-y-yang-sana","name":"Patrick Y. Yang"},"source_id":"governance_people_committees"}` ## Leadership - Hans E. Bishop: Chairman of the Board. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b2fd755c8a73eab3187c46954d00822e778c99ba01b75ed0a78fd62d06bee3e5. - Alise S. Reicin: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c952423d0a179940b53430508c8731f509b7bde93db522ff034206a819543737. - Alise S. Reicin, M.D.: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b2fd755c8a73eab3187c46954d00822e778c99ba01b75ed0a78fd62d06bee3e5. - Joshua H. Bilenker: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:8. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c952423d0a179940b53430508c8731f509b7bde93db522ff034206a819543737. - Joshua H. Bilenker, M.D.: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b2fd755c8a73eab3187c46954d00822e778c99ba01b75ed0a78fd62d06bee3e5. - Mary Agnes Wilderotterº: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:10. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c952423d0a179940b53430508c8731f509b7bde93db522ff034206a819543737. - Michelle Seitz, CFA: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b2fd755c8a73eab3187c46954d00822e778c99ba01b75ed0a78fd62d06bee3e5. - Patrick Y. Yang: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:12. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c952423d0a179940b53430508c8731f509b7bde93db522ff034206a819543737. - Patrick Y. Yang, Ph.D.: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b2fd755c8a73eab3187c46954d00822e778c99ba01b75ed0a78fd62d06bee3e5. - Richard Mulligan: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:14. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c952423d0a179940b53430508c8731f509b7bde93db522ff034206a819543737. - Richard Mulligan, Ph.D.: Vice-Chairman of the Board. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b2fd755c8a73eab3187c46954d00822e778c99ba01b75ed0a78fd62d06bee3e5. - Robert L. Rosiello: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b2fd755c8a73eab3187c46954d00822e778c99ba01b75ed0a78fd62d06bee3e5. - Robert Nelsen: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:17. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c952423d0a179940b53430508c8731f509b7bde93db522ff034206a819543737. - Steven D. Harr, M.D.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b2fd755c8a73eab3187c46954d00822e778c99ba01b75ed0a78fd62d06bee3e5. - Bernard J. Cassidy: Chief Financial Officer. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:19. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:171ab4b96b4749800b94e5a99483733eed38a8827d7bed069c529f4806dde1e3. - Steven D. Harr, M.D.: President and Chief Executive Officer. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b2fd755c8a73eab3187c46954d00822e778c99ba01b75ed0a78fd62d06bee3e5. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - audit committee: Chair not stated; Members Mary Agnes Wilderotterº. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:62ae2933428e3db6e3e528d6d7017273641aa00dc6fef1ca46628320b4a828d1. - compensation and talent committee: Chair not stated; Members Alise S. Reicin. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:62ae2933428e3db6e3e528d6d7017273641aa00dc6fef1ca46628320b4a828d1. - nominating and corporate governance committee: Chair not stated; Members Mary Agnes Wilderotterº; Patrick Y. Yang. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:62ae2933428e3db6e3e528d6d7017273641aa00dc6fef1ca46628320b4a828d1. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Sana Biotechnology, Inc.. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b7182bc54c1646ca65432b91372bdbffe4ce48f9294c0c94ebb48e0149086d8. ## Entity Status - Public listing published. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b7182bc54c1646ca65432b91372bdbffe4ce48f9294c0c94ebb48e0149086d8. ## Published Fact - US. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b7182bc54c1646ca65432b91372bdbffe4ce48f9294c0c94ebb48e0149086d8. ## Committee Appointment - Mary Agnes Wilderotterº: member, audit committee. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:62ae2933428e3db6e3e528d6d7017273641aa00dc6fef1ca46628320b4a828d1. - Alise S. Reicin: member, compensation and talent committee. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:62ae2933428e3db6e3e528d6d7017273641aa00dc6fef1ca46628320b4a828d1. - Mary Agnes Wilderotterº: member, nominating and corporate governance committee. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:62ae2933428e3db6e3e528d6d7017273641aa00dc6fef1ca46628320b4a828d1. - Patrick Y. Yang: member, nominating and corporate governance committee. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:62ae2933428e3db6e3e528d6d7017273641aa00dc6fef1ca46628320b4a828d1. ## Security Listing - SANA (NASDAQ). Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:security_listing:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b7182bc54c1646ca65432b91372bdbffe4ce48f9294c0c94ebb48e0149086d8. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:8b7182bc54c1646ca65432b91372bdbffe4ce48f9294c0c94ebb48e0149086d8: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/sana-biotechnology-inc). - alpha:projection-evidence:document:b2fd755c8a73eab3187c46954d00822e778c99ba01b75ed0a78fd62d06bee3e5: [SEC DEF 14A 0001193125-26-174883](https://www.sec.gov/Archives/edgar/data/1770121/000119312526174883/d42230ddef14a.htm). - alpha:projection-evidence:document:c952423d0a179940b53430508c8731f509b7bde93db522ff034206a819543737: [DEF 14A d42230ddef14a.htm](https://www.sec.gov/Archives/edgar/data/1770121/000119312526174883/d42230ddef14a.htm). - alpha:projection-evidence:document:171ab4b96b4749800b94e5a99483733eed38a8827d7bed069c529f4806dde1e3: [SANA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1770121/000119312526174883/d42230ddef14a.htm). - alpha:projection-evidence:62ae2933428e3db6e3e528d6d7017273641aa00dc6fef1ca46628320b4a828d1: [audit committee](https://www.sec.gov/Archives/edgar/data/1770121/000119312526174883/d42230ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/sana-biotechnology-inc) - [Public Markdown](https://registry.alpha.ac/companies/sana-biotechnology-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=jsonld) - MCP resource: `alpha://companies/sana-biotechnology-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-20T02:45:08.175923+00:00; recorded 2026-10-20T02:45:08.175923+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.